The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Targeted next-generation sequencing (NGS) of circulating tumor cells (CTCs) in hormone-sensitive prostate cancer (HSPC).
Stephen V. Liu
No relevant relationships to disclose
Paul W. Dempsey
Employment or Leadership Position - Cynvenio Biosystems
William Strauss
Employment or Leadership Position - Cynvenio Biosystems
Yucheng Xu
No relevant relationships to disclose
Tong Xu
No relevant relationships to disclose
Jacek K. Pinski
No relevant relationships to disclose
Tanya B. Dorff
No relevant relationships to disclose
David I. Quinn
No relevant relationships to disclose
Timothy J. Triche
No relevant relationships to disclose
Jessamine Winer-Jones
Employment or Leadership Position - Cynvenio Biosystems
Andre De Fusco
Employment or Leadership Position - Cynvenio Biosystems
Janine McMurdie
Employment or Leadership Position - Life Technologies
Amir Goldkorn
No relevant relationships to disclose